| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shah F | Erythromycin. | 1998 | Pediatr Rev | pmid:9557068 |
| Ross JI et al. | Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. | 1998 | Dermatology (Basel) | pmid:9557230 |
| Cleary RK et al. | Metronidazole may inhibit intestinal colonization with Clostridium difficile. | 1998 | Dis. Colon Rectum | pmid:9559631 |
| Rutman A et al. | Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. | 1998 | Antimicrob. Agents Chemother. | pmid:9559781 |
| Barry AL et al. | Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). | 1998 | Antimicrob. Agents Chemother. | pmid:9559816 |
| Roblin PM and Hammerschlag MR | In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9559818 |
| Hoppe JE and Bryskier A | In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). | 1998 | Antimicrob. Agents Chemother. | pmid:9559823 |
| Garcia-Bermejo I et al. | Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain. | 1998 | Antimicrob. Agents Chemother. | pmid:9559831 |
| Mitsuyama T et al. | Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: enhancement by a 14-membered ring macrolide. | 1998 | Mol. Cell. Biochem. | pmid:9562252 |
| Jamkhedkar PP et al. | Clinico-epidemiologic features of granuloma inguinale in the era of acquired immune deficiency syndrome. | 1998 | Sex Transm Dis | pmid:9564722 |
| Delgado LF et al. | Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children. | 1998 | Ann. Allergy Asthma Immunol. | pmid:9564984 |
| Riley RJ and Howbrook D | In vitro analysis of the activity of the major human hepatic CYP enzyme (CYP3A4) using [N-methyl-14C]-erythromycin. | 1997 | J Pharmacol Toxicol Methods | pmid:9566442 |
| Juanqin G et al. | Evaluation of the effectiveness of childhood generalized pustular psoriasis treatment in 30 cases. | 1998 Mar-Apr | Pediatr Dermatol | pmid:9572705 |
| Elliott RL et al. | Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues. | 1998 | J. Med. Chem. | pmid:9572890 |
| Griesgraber G et al. | Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues. | 1998 | J. Med. Chem. | pmid:9572891 |
| Stephenson GA et al. | Formation of isomorphic desolvates: creating a molecular vacuum. | 1998 | J Pharm Sci | pmid:9572901 |
| Piccolomini R et al. | In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. | 1997 | Oral Microbiol. Immunol. | pmid:9573812 |
| Higa F et al. | Simplified quantitative assay system for measuring activities of drugs against intracellular Legionella pneumophila. | 1998 | J. Clin. Microbiol. | pmid:9574712 |
| Hoppe JE | Susceptibility testing of Bordetella pertussis. | 1998 | J. Clin. Microbiol. | pmid:9574735 |
| Bertho G et al. | Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modelling. Ribosome-bound conformation determined by TRNOE and formation of cytochrome P450-metabolite complex. | 1998 | Int. J. Biol. Macromol. | pmid:9585888 |
| Boiron M et al. | Erythromycin elicits opposite effects on antro-bulbar and duodenal motility: analysis in diabetics by cineradiography. | 1997 | Arch. Physiol. Biochem. | pmid:9587651 |
| Goldstein EJ et al. | Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. | 1998 | Antimicrob. Agents Chemother. | pmid:9593139 |
| Spangler SK et al. | Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. | 1998 | Antimicrob. Agents Chemother. | pmid:9593160 |
| Dodhia H and Miller E | Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis. | 1998 | Epidemiol. Infect. | pmid:9593483 |
| de Bethune MP and Nierhaus KH | Characterisation of the binding of virginiamycin S to Escherichia coli ribosomes. | 1978 | Eur. J. Biochem. | pmid:95947 |
| Ng P et al. | Diffuse panbronchiolitis: case report and review of the literature. | 1998 | Australas Radiol | pmid:9599832 |
| Karrer S et al. | [Acne comedonica following radiation therapy]. | 1998 | Dtsch. Med. Wochenschr. | pmid:9601475 |
| Farrell AM et al. | Pyoderma gangrenosum of the penis. | 1998 | Br. J. Dermatol. | pmid:9602887 |
| Paesen J et al. | Study of the stability of erythromycin in a hydrophilic creme basis by liquid chromatography. | 1998 | J Pharm Biomed Anal | pmid:9608426 |
| Kudoh S | Erythromycin treatment in diffuse panbronchiolitis. | 1998 | Curr Opin Pulm Med | pmid:9612675 |
| Mathis C and Malbert CH | Changes in pyloric resistance induced by erythromycin. | 1998 | Neurogastroenterol. Motil. | pmid:9614671 |
| Kudoh S et al. | Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. | 1998 | Am. J. Respir. Crit. Care Med. | pmid:9620913 |
| Kruppa A et al. | Immediate reaction to roxithromycin and prick test cross-sensitization to erythromycin and clarithromycin. | 1998 | Dermatology (Basel) | pmid:9621142 |
| Widdowson CA and Klugman KP | Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. | 1998 Apr-Jun | Emerging Infect. Dis. | pmid:9621199 |
| Rosato A et al. | A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. | 1998 | Antimicrob. Agents Chemother. | pmid:9624482 |
| Muli F and Struthers JK | Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. | 1998 | Antimicrob. Agents Chemother. | pmid:9624489 |
| Kataja J et al. | Different erythromycin resistance mechanisms in group C and group G streptococci. | 1998 | Antimicrob. Agents Chemother. | pmid:9624500 |
| Reinert RR et al. | In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany. | 1998 | Antimicrob. Agents Chemother. | pmid:9624505 |
| Roblin PM and Hammerschlag MR | In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9624507 |
| Souli M et al. | In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. | 1998 | Int. J. Antimicrob. Agents | pmid:9624540 |
| Wirsing von König CH et al. | Factors influencing the spread of pertussis in households. | 1998 | Eur. J. Pediatr. | pmid:9625336 |
| Wandel C et al. | Effect of CYP3A inhibition on vesnarinone metabolism in humans. | 1998 | Clin. Pharmacol. Ther. | pmid:9630823 |
| Stassi DL et al. | Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9636144 |
| Jeffreys AJ and Craig IW | Analysis of proteins synthesized in mitochondria of cultured mammalian cells. An assessment of current approaches and problems in interpretation. | 1976 | Eur. J. Biochem. | pmid:964267 |
| Shryock TR et al. | Antimicrobial susceptibility of Moraxella bovis. | 1998 | Vet. Microbiol. | pmid:9646479 |
| Gharaibeh MN et al. | Effect of multiple doses of rifampin on the [14C N-methyl] erythromycin breath test in healthy male volunteers. | 1998 | J Clin Pharmacol | pmid:9650537 |
| O'Halloran HS et al. | Leber's neuroretinitis in a patient with serologic evidence of Bartonella elizabethae. | 1998 | Retina (Philadelphia, Pa.) | pmid:9654422 |
| Orden B et al. | Erythromycin resistance of Streptococcus pyogenes in Madrid. | 1998 | Pediatr. Infect. Dis. J. | pmid:9655536 |
| Kuyucu N et al. | Comparison of oral erythromycin, local administration of streptomycin and placebo therapy for nonsuppurative Bacillus Calmette-Guérin lymphadenitis. | 1998 | Pediatr. Infect. Dis. J. | pmid:9655549 |
| Azuma A et al. | Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. | 1998 | Thorax | pmid:9659353 |
Erythromycin C
Erythromycin C is a lipid of Polyketides (PK) class.
Cross Reference
